As the disease spread, MAGE-A3, whose normal expression level was 35% in NSCLC changed from 30% in stage I patients to 50% in stage II patients indicating their correlation with poor prognosis [182,183]. The gene discussed is MAGEA3; the disease is non-small cell lung carcinoma.